Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Moderna Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts payable	520)	487)	302)	18)	7)
Provisions related to product sales	556)	—)	—)	—)	—)
Compensation-related	245)	190)	126)	95)	27)
Clinical trials	175)	319)	283)	97)	6)
Manufacturing	167)	400)	227)	53)	6)
Development operations	140)	88)	137)	29)	3)
Other external goods and services	137)	264)	79)	92)	21)
Royalties	122)	203)	241)	—)	—)
Property, plant and equipment	94)	5)	—)	—)	—)
Loss on future firm purchase commitments	79)	268)	—)	—)	—)
Commercial	56)	48)	119)	24)	4)
Raw materials	27)	316)	260)	78)	—)
Accrued liabilities	1,798)	2,101)	1,472)	470)	68)
Deferred revenue	568)	2,038)	6,253)	3,867)	63)
Income taxes payable	63)	48)	876)	—)	—)
Financing lease liabilities, current	—)	161)	165)	24)	—)
Operating lease liabilities, current	25)	35)	46)	6)	4)
Other	41)	53)	14)	3)	1)
Other current liabilities	66)	249)	225)	34)	5)
Current liabilities	3,015)	4,923)	9,128)	4,389)	143)
Deferred revenue, non-current	83)	673)	615)	177)	139)
Operating lease liabilities, non-current	643)	92)	106)	97)	94)
Financing lease liabilities, non-current	575)	912)	599)	110)	39)
Other non-current liabilities	256)	135)	76)	2)	—)
Non-current liabilities	1,557)	1,812)	1,396)	387)	271)
Total liabilities	4,572)	6,735)	10,524)	4,775)	415)
Preferred stock, $0.0001; no shares issued or outstanding	—)	—)	—)	—)	—)
Common stock, par value $0.0001	—)	—)	—)	—)	—)
Additional paid-in capital	371)	1,173)	4,211)	4,802)	2,669)
Accumulated other comprehensive income (loss)	(123)	(370)	(24)	3)	2)
Retained earnings (accumulated deficit)	13,606)	18,320)	9,958)	(2,244)	(1,496)
Stockholders’ equity	13,854)	19,123)	14,145)	2,561)	1,175)
Total liabilities and stockholders’ equity	18,426)	25,858)	24,669)	7,337)	1,589)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Download chart

Balance sheet item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	Moderna Inc. current liabilities decreased from 2021 to 2022 and from 2022 to 2023.
Non-current liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	Moderna Inc. non-current liabilities increased from 2021 to 2022 but then slightly decreased from 2022 to 2023 not reaching 2021 level.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	Moderna Inc. total liabilities decreased from 2021 to 2022 and from 2022 to 2023.
Stockholders’ equity	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	Moderna Inc. stockholders’ equity increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.

Moderna Inc. (NASDAQ:MRNA)

Balance Sheet: Liabilities and Stockholders’ Equity